Taiko Pharmaceutical Company., Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Taiko Pharmaceutical Company., Limited with three other
pharmaceutical manufacturers in Asia:
Wai Yuen Tong Medicine Holdings Ltd
of Hong Kong
sales of 738.44 million Hong Kong Dollars [US$94.56 million]
Ttk Healthcare Limited
(5.33 billion Indian Rupees [US$82.73 million]
of which 52%
was Pharmaceuticals), and
Yuyu Pharma Incorporated
based in South Korea
(71.58 billion Korean Won [US$63.99 million]
Taiko Pharmaceutical Company., Limited reported sales of ¥8.29 billion (US$74.57 million)
March of 2017.
decrease of 0.4%
versus 2016, when the company's sales were ¥8.33 billion.
Contributing to the drop in overall sales was the 39.1% decline
in Other, from ¥23.78 million to ¥14.48 million.
There were also decreases in sales in
Medicine Goods (down 17.1% to ¥5.04 billion)
However, these declines were partially offset by the increase in sales of
Infection Control (up 45.6% to ¥3.24 billion)